Discover new workout ideas, healthy-eating recipes, makeup looks, skin-care advice, the best beauty products and tips, trends, and more from SELF.

For decades, many runners, and even coaches, have assumed that being a runner meant never walking during a training run or race. Even the most accomplished runners would apologize when they walked at ...

Corrections & clarifications: A previous version of this story incorrectly stated the type of eclipse occurring on Aug. 27, 2026. The Aug. 27-28 event is a lunar eclipse. The next total solar eclipse ...

・Joby CEO JoeBen Bevirt said the eIPP program will enable the company to operate its aircraft in real environments before certification. ・Operating costs surged to $257.8 million, up from $163 million ...

I read your response to the woman who wondered why she should invest in Social Security when the stock market would have been far more lucrative (“If I had invested my Social Security in the S&P 500 I ...

Doug Wintemute is a staff writer for Forbes Advisor. After completing his master’s in English at York University, he began his writing career in the higher education space. Over the past decade, Doug ...

A licensed attorney with nearly a decade of experience in content production, Valerie Catalano knows how to help readers digest complicated information about the law in an approachable way. Her ...

Editor Darius Helm reports on the state of commercial vinyl flooring, including environmental progress, trends, new technologies and highlights from leading manufacturers, as well as a short report on ...

・Atomera’s Q1 revenue dropped sharply to $11,000, down from $50,000 last year. ・The company remains unprofitable, spending more than $6 million in Q1. ・Atomera CEO Scott Bibaud said the key challenge ...

As the UK prepares itself for another heatwave, we’re experiencing mixed emotions. Having survived an especially wet winter, many people are welcoming prospect of dry, sun-drenched conditions, which ...

- Global strategic collaboration with Astellas to advance PSMA-targeted, PRO-XTEN ® dual-masked T-cell engager (TCE) VIR-5500 closed and first patient dosed in Phase 1 dose-expansion cohorts in ...